Literature DB >> 7678015

Typing of human rotavirus VP4 by an enzyme immunoassay using monoclonal antibodies.

B S Coulson1.   

Abstract

Two different neutralization specificities exist on the outer capsid of group A rotaviruses. At least seven VP7 (G) antigenic types are distinguishable among human rotaviruses. Four distinct antigenic (P) types of human rotavirus VP4 corresponding to separate rotavirus gene 4 groups have been described. The aim of this study was to identify P types in clinical specimens by developing an enzyme immunoassay, using P-type-specific neutralizing monoclonal antibodies (N-MAbs). Three N-MAbs primarily or solely recognizing each of P types 4, 6, and 8 and binding to VP4 or its subunit VP5* were derived. These N-MAbs served as detector antibodies in an enzyme immunoassay P-typing system similar to that in use for G typing. P-type specificity was highest when the G-type specificity of the capture antiserum was matched to the G type of the rotavirus in the test sample. The method correctly identified the P types of 13 well-characterized, cell culture-adapted human rotaviruses and was used to classify a further six strains. P typing of 118 rotavirus-positive stools gave results consistent with the P type inferred from the G type for 98 (83%) samples. Twelve (10%) of the stools showed no reaction with any N-MAb and eight (7%) samples were untypeable because of cross-reactivity between N-MAbs or high background readings. This P-typing enzyme immunoassay system is economical and amenable to large-scale use in epidemiological studies. Its use will facilitate assessment of the distribution of P types worldwide and of the role of VP4 in eliciting protective immune responses.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678015      PMCID: PMC262611          DOI: 10.1128/jcm.31.1.1-8.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  36 in total

1.  Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3.

Authors:  B S Coulson; J M Tursi; W J McAdam; R F Bishop
Journal:  Virology       Date:  1986-10-30       Impact factor: 3.616

2.  Experience with an enzyme immunoassay for serotyping human group A rotaviruses.

Authors:  L E Unicomb; B S Coulson; R F Bishop
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

3.  Simple and specific enzyme immunoassay using monoclonal antibodies for serotyping human rotaviruses.

Authors:  B S Coulson; L E Unicomb; G A Pitson; R F Bishop
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

4.  Genetic analysis of a human rotavirus that belongs to subgroup I but has an RNA pattern typical of subgroup II human rotaviruses.

Authors:  O Nakagomi; T Nakagomi; Y Hoshino; J Flores; A Z Kapikian
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

5.  Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype 1-, 2-, 3-, and 4-specific monoclonal antibodies to VP7.

Authors:  K Taniguchi; T Urasawa; Y Morita; H B Greenberg; S Urasawa
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

6.  Comparative sensitivities of solid-phase immune electron microscopy and enzyme-linked immunosorbent assay for serotyping of human rotavirus strains with neutralizing monoclonal antibodies.

Authors:  G Gerna; A Sarasini; B S Coulson; M Parea; M Torsellini; E Arbustini; M Battaglia
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

7.  Isolation and serotyping of animal rotaviruses and antigenic comparison with human rotaviruses. Brief report.

Authors:  M J Albert; L E Unicomb; S R Tzipori; R F Bishop
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

8.  Serotypic analysis of VP3 and VP7 neutralization escape mutants of rhesus rotavirus.

Authors:  R D Shaw; E R Mackow; M L Dyall-Smith; I Lazdins; I H Holmes; H B Greenberg
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

9.  Neutralizing monoclonal antibodies against three serotypes of porcine rotavirus.

Authors:  H S Nagesha; L E Brown; I H Holmes
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

10.  Identification of group A rotavirus gene 4 types by polymerase chain reaction.

Authors:  J R Gentsch; R I Glass; P Woods; V Gouvea; M Gorziglia; J Flores; B K Das; M K Bhan
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

View more
  23 in total

1.  Rotavirus Vaccines: Current Controversies and Future Directions.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

2.  Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995.

Authors:  L E Unicomb; G Podder; J R Gentsch; P A Woods; K Z Hasan; A S Faruque; M J Albert; R I Glass
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

3.  Rotavirus replication in intestinal cells differentially regulates integrin expression by a phosphatidylinositol 3-kinase-dependent pathway, resulting in increased cell adhesion and virus yield.

Authors:  Peter Halasz; Gavan Holloway; Stephen J Turner; Barbara S Coulson
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

4.  Nucleotide sequence and expression in E. coli of the complete P4 type VP4 from a G2 serotype human rotavirus.

Authors:  N P Mahajan; C D Rao
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

5.  Antigenic and genomic diversity of human rotavirus VP4 in two consecutive epidemic seasons in Mexico.

Authors:  L Padilla-Noriega; M Méndez-Toss; G Menchaca; J F Contreras; P Romero-Guido; F I Puerto; H Guiscafré; F Mota; I Herrera; R Cedillo; O Muñoz; J Calva; M L Guerrero; B S Coulson; H B Greenberg; S López; C F Arias
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

6.  Comparison of enzyme immunoassay, PCR, and type-specific cDNA probe techniques for identification of group A rotavirus gene 4 types (P types).

Authors:  P J Masendycz; E A Palombo; R J Gorrell; R F Bishop
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

7.  Production of reassortant viruses containing human rotavirus VP4 and SA11 VP7 for measuring neutralizing antibody following natural infection.

Authors:  R J Gorrell; R F Bishop
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

8.  Structural basis of rotavirus strain preference toward N-acetyl- or N-glycolylneuraminic acid-containing receptors.

Authors:  Xing Yu; Vi T Dang; Fiona E Fleming; Mark von Itzstein; Barbara S Coulson; Helen Blanchard
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

9.  Rotavirus diarrhea severity is related to the VP4 type in Mexican children.

Authors:  Felipe Mota-Hernández; Juan José Calva; Claudia Gutiérrez-Camacho; Sofía Villa-Contreras; Carlos F Arias; Luis Padilla-Noriega; Héctor Guiscafré-Gallardo; María de Lourdes Guerrero; Susana López; Onofre Muñoz; Juan F Contreras; Roberto Cedillo; Ismael Herrera; Fernando I Puerto
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites.

Authors:  C D Kirkwood; R F Bishop; B S Coulson
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.